Recordati Industria Chimica e Farmaceutica Balance Sheet Health
Financial Health criteria checks 3/6
Recordati Industria Chimica e Farmaceutica has a total shareholder equity of €1.8B and total debt of €1.7B, which brings its debt-to-equity ratio to 93.9%. Its total assets and total liabilities are €4.3B and €2.5B respectively. Recordati Industria Chimica e Farmaceutica's EBIT is €641.0M making its interest coverage ratio 8.4. It has cash and short-term investments of €294.7M.
Key information
93.9%
Debt to equity ratio
€1.71b
Debt
Interest coverage ratio | 8.4x |
Cash | €294.65m |
Equity | €1.82b |
Total liabilities | €2.46b |
Total assets | €4.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RECm's short term assets (€1.3B) exceed its short term liabilities (€973.2M).
Long Term Liabilities: RECm's short term assets (€1.3B) do not cover its long term liabilities (€1.5B).
Debt to Equity History and Analysis
Debt Level: RECm's net debt to equity ratio (77.7%) is considered high.
Reducing Debt: RECm's debt to equity ratio has increased from 71% to 93.9% over the past 5 years.
Debt Coverage: RECm's debt is well covered by operating cash flow (31%).
Interest Coverage: RECm's interest payments on its debt are well covered by EBIT (8.4x coverage).